Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:59 AM
Ignite Modification Date:
2025-12-25 @ 2:59 AM
NCT ID:
NCT00962533
Eligibility Criteria:
Inclusion Criteria:
* Male or female, from 18 (inclusive) to 65 (inclusive) years of age
* HBsAg and HBeAg positive for over six months
* Patient is willing and able to comply with the study drug regimen and all other study requirements
* Patients must give written informed consent before any assessment is performed
Exclusion Criteria:
* Detected M204I/V, N236T, A181V/T mutation in patient serum HBV DNA at Screening visit
* Patient has a history of or clinical signs/symptoms of hepatic decompensation
* Patient has a history of hepatocellular carcinoma (HCC) or findings suggestive of possible HCC
* Other protocol-defined inclusion/exclusion criteria may apply
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT00962533
Study Brief:
Protocol Section:
NCT00962533